Aortic atherosclerosis and stroke

Journal of Stroke and Cerebrovascular Diseases

Volumn 6, Issue 3, 1997, Pages 125-129

  Briley, Dennis P ^a   Lababidi, Zaki ^a   Bowdler, Anthony J ^a   Krishnamurthy, M ^a   Cansino, Silvestre P ^a   Touchon, Robert C ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aortic atherosclerosis; Fibrinogen; Plasma viscosity; Stroke; Transesophageal echocardiography

Indexed keywords

EID: 0345708671     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1052-3057(97)80228-5     Document Type: Article

References (26)

1. Amarenco P., Duyckaerts C., Tzourio C., Hénin D., Bousser M.-G., and Hauw J.-J. The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med 326 (1992) 221-225
2. Karalis D.G., Chandrasekaran K., Victor M.F., Ross J.J., and Mintz G.S. Recognition and embolic potential of intraaortic atherosclerotic debris. J Am Coll Cardiol 17 (1991) 73-78
3. Stone D.A., Hawke M.W., LaMonte M., Kittner S.J., Acosta J., Corretti M., et al. Ulcerated atherosclerotic plaques in the thoracic aorta are associated with cryptogenic stroke: a multiplane transesophageal echcardiographic study. Am Heart J 130 (1995) 105-108
4. Labovitz A.J., Camp A., Castello R., Martin T.J., Ofili E.O., Rickmeyer N., et al. Usefulness of transesophageal echocardiography in unexplained cerebral ischemia. Am J Cardiol 72 (1993) 1448-1452
5. Di Tullio M.R., Sacco R.L., Gersony D., Nayak H., Weslow R.G., Kargman D.E., et al. Aortic atheromas and acute ischemic stroke: a transesophageal echocardiographic study in an ethnically mixed population. Neurology 46 (1996) 1560-1566
6. The French Study of Aortic Plaques in Stroke Group. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med 334 (1996) 1216-1221
7. Amarenco P., Cohen A., Tzourio C., Bertrand B., Hommel M., Besson G., et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 331 (1994) 1474-1479
8. Jones E.F., Kalman J.M., Calafiore P., Tonkin A.M., and Donnan G.A. Proximal aortic atheroma: an independent risk factor for cerebral ischemia. Stroke 26 (1995) 218-224
9. Coull B.M., Beamer N., de Garmo P., Sexton G., Nordt F., Knox R., et al. Chronic blood hyperviscosity in subjects with acute stroke, transient ischemic attack, and risk factors for stroke. Stroke 22 (1991) 162-168
10. Yarnell J.W.G., Baker I.A., Sweetnam P.M., Bainton D., O'Brien J.R., Whithead P.J., et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. Circulation 83 (1991) 836-844
11. Resch K.L., Ernst E., Matrai A., and Paulsen H.F. Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivors. Ann Intern Med 117 (1992) 371-375
12. Ernst E., and Resch K.L. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 118 (1993) 956-963
13. Kannel W.B., Wolf P.A., Castelli W.P., and D'Agostino R.B. Fibrinogen and risk of cardiovascular disease: the Framingham study. JAMA 258 (1987) 1183-1186
14. Thompson S.G., Kienast J., Pyke S.D.M., Haverkate F., and van de Loo J.C.W. The European Concerted Action on Thrombosis and Disabilities Angina Pectoris Group. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 332 (1995) 635-641
15. Adams H.P., Bendixen B.H., Kappelle L.J., Biller J., Love B.B., Gordon D.L., et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 24 (1993) 35-41
16. Stata Corporation. Stata reference manual; Release 3.1. 6th ed. (1993), Strata Corporation, College Station, TX
17. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344 (1994) 1383-1389
18. Furberg C.D., Adams H.P., Applegate W.B., Byington R.P., Espeland M.A., Hartwell T., et al., The Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Circulation 90 (1994) 1679-1687
19. Crouse III J.R., Byington R.P., Bond M.G., Espeland A., Craven T.E., Sprinkle J.W., et al. Pravastatin, lipids and atherosclerosis in the carotid arteries (PLAC-II). Am J Cardiol 75 (1995) 455-459
20. Tunick P.A., Rosenzweig B.P., Katz E.S., Freedberg R.S., Perez J.L., and Kronzon I. High risk for vascular events in patients with protuding aortic atheromas: a prospective study. J Am Coll Cardiol 23 (1994) 1085-1090
21. Lowe G. Blood viscosity, lipoproteins, and cardiovascular risk. Circulation 85 (1992) 2329-2331
22. Ducimetiere P., Warnet J.M., and Richard J.L. Raised serum alpha-2 globulins as an independent risk factor of coronary heart disease. J Chron Dis 29 (1976) 423-429
23. van der Wal A.C., Becker A.E., van der Loos C.M., and Das P.K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89 (1994) 36-44
24. (part 1). Fuster V., Badimon L., Badimon J.J., and Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 326 (1992) 242-250
25. (part 2). Fuster V., Badimon L., Badimon J.J., and Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 326 (1992) 310-318
26. National Cholesterol Education Program. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel II). Circulation 89 (1994) 1329-1445